Clinical Trial Update: Sulfasalazine in Decreasing Opioids Requirements in Breast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating sulfasalazine to reduce opioid requirements in breast cancer patients with cancer-related pain. The study is completed and results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: University of Arizona | Conditions: Breast Cancer, Chronic Pain Due to Malignancy (Finding) | Phase 2 | Status: COMPLETED | Results posted: 2025-01-09